Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metastatic Castration-Resistant Prostate Cancer × inavolisib × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Castration-Resistant Prostate Cancer 1

Interventions

enzalutamide 7 abiraterone 3 Prednisone 3 Docetaxel 3 Abiraterone Acetate 3 sapanisertib 1 relugolix 1 pembrolizumab 1 onvansertib 1 olaparib 1 lenvatinib 1 inavolisib 1 belzutifan 1 apalutamide 1 abemaciclib 1 PF06821497 1 Methylprednisolone 1 Lutetium-177 1 Lutetium 1 Gonadotropin-Releasing Hormone 1 Etoposide 1 Diagnostic Tests, Routine 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07287150 2026-03-05

InavoPC

Hoffmann-La Roche

Phase 2 Recruiting

Metastatic Castration-Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡